Recipharm AB publ announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was SEK 2,968.9 million compared to SEK 2,090 million a year ago. Operating income was SEK 339.2 million compared to SEK 116.8 million a year ago. Net income was SEK 223 million compared to SEK 89.4 million a year ago. For the full year, total revenue was SEK 11,445.8 million compared to SEK 7,709.3 million a year ago. Operating income was SEK 841.6 million compared to SEK 493.9 million a year ago. Net income was SEK 338.7 million compared to SEK 343.1 million a year ago.